Abstract: The present disclosure provides a composition. In an embodiment an adhesive composition is provided and includes A) a propylene based plastomer or elastomer (PBPE) comprising up to 10 wt % units derived from ethylene and having (i) a Koenig B-value less than 1.0; (ii) a total unsaturation per mole of propylene from 0.01% to 0.03%; (iii) a density from 0.870 g/cc to 0.890 g/cc; (iv) a melt viscosity at 177° C. from 800 mPa·s to 11,000 mPa·s; and (v) a weight average molecular weight from 20,000 to 50,000 g/mol; B) a tackifier; and C) a wax.

Abstract: The present disclosure provides an article. The article includes a first substrate comprising a first propylene-based polymer and a second substrate comprising a second propylene-based polymer. The article includes an adhesive composition located between the first substrate and the second substrate. The adhesive composition includes (A) a block composite compatibilizer, (B) an ethylene-based polymer or a propylene-based polymer, (C) a tackifier, and (D) a wax. The adhesive composition bonds the first substrate to the second substrate with improved a lap shear strength.

Abstract: An integrated eliminating device and its method for initial runoff pollution is provided, wherein a plurality of the water receiving pipes for collecting initial runoff are gathered and connected to the first water reservoir, one end of the water inlet pump is connected with the first water reservoir via the water receiving pipes, and the other end of the intake pump is connected with an water inlet opening of the rice field; the rice field is divided into a plurality of sub-parcels in a shape of long stripes, a regulating gate is set. An outlet of the rice field is communicated with the second water reservoir and which is communicated with the water inlet opening of the rice field via the reflux pump.

Abstract: The present invention relates to a composition for a gel polymer electrolyte and a lithium secondary battery including the same, and more specifically, an objective of the present invention is to provide a secondary battery in which, since an isocyanate-containing monomer is introduced to a composition for a gel polymer electrolyte to induce a urethane reaction with LiOH on a surface of a lithium transition metal oxide to form a coating layer including a urethane bond-containing oligomer on the surface of the lithium transition metal oxide, and thereby side reactions caused by HF in the battery are minimized, capacity characteristics are improved, and adhesion between a positive electrode and a separator is enhanced to minimize the swelling phenomenon of the battery.

Abstract: Described are methods, devices, and systems for a novel, inexpensive, easy to use therapy for treatment of coma, post-traumatic stress disorder, Parkinson's disease, cognitive performance, and/or amblyopia. Described are methods and devices to treat coma, post-traumatic stress disorder, Parkinson's disease, cognitive performance, and/or amblyopia that involves no medication. Methods and devices described herein use alternating magnetic fields to gently “tune” the brain and affect symptoms of coma, post-traumatic stress disorder, Parkinson's disease, cognitive performance, and/or amblyopia.

Abstract: A memory device may include the following elements: a first memory cell; a first word line for transmitting a first control signal to control an electrical connection in the first memory cell; a first bit line connected to the first memory cell; a first transistor, wherein a first terminal of the first transistor is connected to the first bit line; a second memory cell; a second word line for transmitting a second control signal to control an electrical connection in the second memory cell; a second bit line connected to the second memory cell; a second transistor, wherein a first terminal of the second transistor is connected to the second bit line; and a sense amplifier having a first input terminal connected to a second terminal of the first transistor and having a second input terminal connected to a second terminal of the second transistor.

Abstract: High frequency repetitive magnetic pulses may be used to treat pain in the foot of a person by relaxing the muscle and reducing communication of pain signals by neurons in the treatment region. A device is disclosed, which is floor mounted and incorporates a cooling mechanism and heat sink to allow high frequency magnetic stimulation to the person's foot.

Abstract: Flooding compounds for telecommunications cables. Such flooding compounds contain a polymeric filler and a branched olefinic fluid. The branched olefinic fluid has an average of at least 1.5 methine carbons per oligomer molecule and at least 40 methine carbons per one thousand total carbons. Additionally, the average number of carbons per molecule in the branched olefinic fluid is from 25 to 200.

Abstract: Repetitive Transcranial Magnetic Stimulation (rTMS) is administered at a pulse frequency that is optimized with respect to settling time of the EEG oscillations, measured at the pulse frequency. Pulse frequency is adjusted following each pulse train to achieve a maximum settling time. A device is disclosed which is configured to allow for magnetic pulse frequency optimization.

Abstract: The invention provides compositions, each comprising an ethylene/alpha-olefin interpolymer, which has a reduced level of a low density, low molecular weight oligomeric fraction, as indicated by an HCC value, as described herein, and reduced levels of inorganic content or lower Tm. The invention also provides processes for forming such interpolymers.

Abstract: Flooding compounds for telecommunications cables. Such flooding compounds contain a polyolefin elastomer and a hydrocarbon oil. The polyolefin elastomer has a crystallinity ranging from 10 less than 50 weight percent and a dynamic viscosity of 50,000 centipoise or less at 177° C. The hydrocarbon oil has a kinematic viscosity of 200 centistokes or less at 40° C.

Abstract: Described are methods for the improvement of neural communication between implanted and existing tissue. Methods herein use synchronous low frequency magnetic or electric stimulation of both regions to enhance communication and facilitate regeneration of nerve fibers across the tissue interface.

Abstract: The present invention pertains to carpet and carpet tile. In one aspect, the carpet includes (a) a primary backing which has a face and a back surface, (b) a plurality of fibers attached to the primary backing and extending from the face of the primary backing and exposed at the back surface of the primary backing, (c) an adhesive backing, (d) an optional secondary backing adjacent to the adhesive backing, and (e) at least one non-chlorinated, non-polyvinyl butyral thermoplastic polymer or composition having a specific growth tension at 40 C and a specific residual stress at 25% strain. Additional steps and procedures include washing or scouring the primary backing and fibers prior to the extrusion step, and utilizing implosion agents. The preferred olefin block copolymer are ethylene based block interpolymers. The constructions and methods described herein are particularly suited for making tufted, broad-loom carpet having improved abrasion resistance.

Abstract: The invention provides compositions, each comprising an ethylene/alpha-olefin interpolymer, which has a reduced level of a low density, low molecular weight oligomeric fraction, as indicated by an HCC value, as described herein, and reduced levels of inorganic content or lower Tm. The invention also provides processes for forming such interpolymers.

Abstract: A non-volatile memory (NVM) includes at least one memory unit region, each including a memory array and having first memory cells in the odd columns and second memory cells in the even columns. Corresponding to each memory unit region, the NVM includes a multiplexer including first bit line decoders and second bit line decoders, a comparator circuit including a first input terminal and a second input terminal, and a bias generation circuit generating a bias voltage. When reading a data information from a first memory cell, a first output voltage of the first memory cell is sent to the first input terminal and the bias voltage is sent to the second input terminal. When reading a data information from a second memory cell, a second output voltage of the second memory cell is sent to the second input terminal and the bias voltage is sent to the first input terminal.

Abstract: Various biodegradable polyglutamate-amino acids comprising recurring units of the general formulae (I) and (II) are prepared. Such polymers are useful for variety of drug, biomolecule and imaging agent delivery applications.

Abstract: Described herein are methods of lowering the endotoxin content from a polyanionic polymer conjugate. In particular, methods of reducing the endotoxin content from a polyanionic polymer conjugate that can be useful for a variety of drug delivery applications are described herein.

Abstract: The present invention relates to an electrode for a secondary battery including an electrode current collector, an electrode active material combination layer formed on one or both sides of the electrode current collector, and a polyurethane-based coating layer formed on the electrode active material combination layer, and a lithium secondary battery including the same.

Abstract: The invention provides a method of assessing the appropriate therapeutic dose of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyi-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid to administer to a patient in need thereof, comprising the steps of: (i) testing whether or not the patient has the poor metabolizer genotype; and (ii) if the patient does not have the poor metaboliser genotype, administering 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid, or a pharmaceutically acceptable salt thereof, to the patient at the standard therapeutic dose; and (iii) if the patient does have the poor metaboliser genotype, either (a) administering 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid, or a pharmaceutically acceptable salt thereof, to the patient at a therapeutic dose below that of the standard therapeutic dose; or (b) not administering 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxy

Abstract: Described herein, in certain embodiments, are devices and methods for modulating the electrical activity of a brain in a targeted manner using a weak magnetic field, generally field with a strength of less than about 100 Gauss. The magnetic field is varied over time in a periodic manner, generally with a frequency tuned to specifically affect one of the intrinsic frequencies of the brain, optionally the alpha frequency. The “Low Field Magnetic Stimulation” devices and methods described herein modulate the electrical activity of a brain without requiring medication. Methods and devices described herein gently “tune” the brain and affect mood, focus, and cognition of human subjects.